← Browse by Condition

Medical Condition

hiv

Total Trials

38

Recruiting Now

38

Trial Phases

Phase 4, Phase 2, Phase 1, Phase 2

ClinicalMetric tracks all active clinical trials for hiv sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — hiv Clinical Trials

How many clinical trials are currently recruiting for hiv?

ClinicalMetric currently tracks 38 actively recruiting clinical trials for hiv, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 38. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for hiv?

hiv research spans Phase 1 (1 trial), Phase 2 (4 trials), Phase 4 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a hiv clinical trial?

Eligibility criteria for hiv trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 1

1

Phase 2

4

Phase 4

2

Top Sponsors

University of California, San Francisco 2 trials

University of Washington 2 trials

University of Texas Southwestern Medical Center 2 trials

Boston University 2 trials

University of Connecticut 1 trial

Recruiting Clinical Trials

NCT05669534 Phase 4

Optimizing Evidence-based HIV Prevention Targeting People Who Inject Drugs on PrEP

University of Connecticut

The Role of Ectopic Fat and Heart Attack Risk in HIV

University of Liverpool

Peer-led Implementation of TB-HIV Education and Adherence Counseling in Uganda

Yale University

Text Education About Cardiovascular Health and HIV (TEACH-HIV)

University of California, San ...

Enhancing Wellness Through Affirming Services and Education

Duke University

Predictors of Health Service Utilizations Among Key Population in Washington DC

Us Helping Us, People Into Liv...

Optimization of Cervical Cancer Screening Strategies Among Women Living With HIV: Effectiveness and Implementation of Decentralized Approach Using a Mobile Team With HPV Testing in the Western Region of Cameroon

Institut de Recherche pour le ...

Bridge to Belonging: Peer Led Intervention to Reduce Loneliness and Depression Among Older Gay and Bisexual Men

Fenway Community Health

Healthy Behaviors for Insomnia Prevention in People With HIV and Ongoing Pain

Washington University School o...

Kulindana: Community-friendly Delivery and Monitoring of TPT to Improve Uptake and Reduce TB Transmission

University of Washington

Leukapheresis Procedures to Obtain Plasma and Lymphocytes for Research Studies on Antiretroviral Naive HIV-1 Research Participants

National Institute of Allergy ...

Skeletal Muscle Energetics and Fatiguability in Older Individuals

Johns Hopkins University

A Seek, Test, and Treat Intervention to Reduce Chlamydia Trachomatis Disparities

Tulane University

Collection of Blood for Multiple Collaborative Studies

University of California, San ...

Gathering Online for Dialogue and Discussion to Enhance Social Support

RTI International

Improving Engagement in HIV and Cancer Care in Zimbabwe

Fred Hutchinson Cancer Center

HIV/HBV/HCV Triple Screening in Primary Care

University of Texas Southweste...

Improving Perinatal Outcomes Among Kenyan Pregnant Women With an Integrated STI Testing Model

University of Washington

A Pilot Project for PLWH Aged 65-75: Preventing the Development of Frailty

Centre Hospitalier Universitai...

NCT05570812 Phase 2

Neuroactive Steroid to Treat Depressed Mood: A Trial for People With HIV

Massachusetts General Hospital

Pasteurized Donor Human Milk for HIV-Exposed Infants: A Pilot Study

University of Saskatchewan

Enhancing Uptake of Needle and Syringe Programs in Canadian Federal Prisons

McGill University Health Centr...

German Centre for Infection Research HIV Translational Platform

University Hospital of Cologne

RESTORE Study R61 Phase: Recovery and Engagement for Stimulant Users on Re-entry

University of Texas Southweste...

NCT07221214 Phase 2

GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV

Vanderbilt University Medical ...

Vicente Ferrer HIV Cohort Study

Rural Development Trust Hospit...

NCT07054931 Phase 2

Combination Vaccination and Broadly Neutralising Antibody Therapy in HIV

University of Oxford

Behavioral Risk Identification and Decision Guidance for HIV Engagement

Boston University

We-INtervention Among Chinese HIV-serodiscordant Male Couples

City University of Hong Kong

Project Vuselela Feasibility

Arizona State University

Optimizing Tobacco Treatment Delivery for People Living With HIV

Medical University of South Ca...

Gathering Records to Evaluate Antiretroviral Treatment-Malawi ( GREAT )

Boston University

Testing Two Interventions to Improve Health Outcomes and Quality of Life Among Rural Older Adults Living With HIV

Medical College of Wisconsin

Identifying Challenges to Healthy Aging in Persons With Human Immunodeficiency Virus (HIV) Age 50 and Older

Wake Forest University Health ...

NCT06967753 Phase 4

Switch to Dolutegravir Plus Lamivudine Dual-Therapy in Transgender Women Living With HIV on Virologically Suppressive Antiretroviral Therapy (TRANS-SWITCH)

HIV Prevention Intervention for Latino Male Couples

University of Central Florida

Care Disengagement Prevention in PLWH in Indonesia

University of California, Los ...

NCT07433387 Phase 1, Phase 2

Exploratory Study of LP-98 for Injection in ART-Naive HIV-Infected Individuals

Shanxi Kangbao Biological Prod...

Related Conditions

tuberculosis (2) pre exposure prophylaxis (2) smoking cigarette (2) opioid use disorder (1) cardiometabolic syndrome (1) human immunodeficiency virus (1) cardiovascular diseases (1) atherosclerosis (1) mental health disorder (1) substance use (1) health behavior (1) cervical cancer screening (1)

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology